IP Library Granted Patent US 12,674,049
Granted Patent B2
US 12,674,049 · App. 19/011,814 · Granted Jul 7, 2026

Polymer processing aids

Inventors: Michael A Leaf (Baytown, TX); Danny Van Hoyweghen (Heverlee, BE); Haiqing Peng (Sugar Land, TX); Petra M. Eiselt (Houston, TX); Luke A. Galuska (Crosby, TX)
Assignee: ExxonMobil Technology and Engineering Company
C08L23/0815B29C48/022B29C48/10C08J5/18B29K2023/0625B29K2067/00B29K2077/00B29K2085/00B29K2105/0088B29K2995/0012B29K2995/0088B29K2995/0094C08J2323/08C08J2477/04C08J2485/02C08L2203/16C08L2205/03C08L2205/06C08L2310/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,049
App. No.
19/011,814
Filed
Jan 7, 2025
Granted
Jul 7, 2026
Kind
B2
Art Unit
1765
USPC
525/166
Abstract

Methods and compositions for processing polymers with fluorine-free polymer processing aids (PPAs) are described. The methods can include extruding a polymer composition, optionally with a masterbatch, wherein the polymer composition and/or the masterbatch comprises a fluorine-free PPA to make a polymeric film. The PPA comprises a mixture of one or more polyamides and one or more polyphosphites.

Claims (62)

1 . A polymer composition comprising:

a C 2 -C 6 olefin homopolymer or a copolymer of two or more C 2 -C 20 α-olefins; and

a polymer processing aid;

wherein:

the polymer processing aid comprises a mixture of one or more polyamides and one or more polyphosphites;

the one or more polyamides are selected from a group consisting of aliphatic polyamides;

the mixture is present in the polymer composition in an amount in the range of from 560 ppm to 4,400 ppm; and

the polymer composition is substantially free of fluorine.

2 . The polymer composition of claim 1 , wherein the mixture is present in the polymer processing aid in an amount greater than or equal to 80 wt %.

3 . The polymer composition of claim 1 , wherein the weight ratio of the one or more polyamides to the one or more polyphosphites is in the range of from 6:1 to 1:25.

4 . The polymer composition of claim 1 , wherein the one or more polyamides is present in the polymer composition in an amount in the range of from 160 ppm to 2,200 ppm.

5 . The polymer composition of claim 1 , wherein each of the one or more polyamides comprises particulate matter having a particle size in the range of from 2 to 1,500 microns.

6 . The polymer composition of claim 1 , wherein each of the one or more polyamides has:

a low load melt index (LLMI) according to ASTM D-1238, 2.16 kg at 230° C. in the range of from 30 dg/min to 50 dg/min;

a medium load melt index (MLMI) according to ASTM D-1238, 5 kg at 230° C. in the range of from 110 dg/min to 160 dg/min; or

a combination thereof.

7 . The polymer composition of claim 1 , wherein the one or more polyphosphites is present in the polymer composition in an amount in the range of from 400 ppm to 2,200 ppm.

8 . The polymer composition of claim 1 , wherein each of the one or more polyphosphites comprises an alkyl polyphosphite, an aryl polyphosphite, a cyclic polyphosphite, an oligomeric polyphosphite, a mixed polyphosphite, a high-performance phosphite polymer, or a combination thereof.

9 . The polymer composition of claim 8 , wherein the one or more polyphosphites are described by one or more of Formula (I), Formula (II), Formula (III), and Formula (IV), as shown below:

wherein:

each R 1 , R 2 , R 3 and R 4 can be the same or different and independently selected from the group consisting of C 12-20 alkyl, C 12-22 alkenyl, C 12-40 cycloalkyl, C 12-40 cycloalkylene, C 12-20 alkyl glycol ethers and Y—OH as an end-capping group;

each Y is independently selected from the group consisting of C 2-40 alkylene, C 7-40 cycloalkylene, C 3-20 alkyl glycol ethers, C 3-40 alkyl lactone, and —R 7 —N(R 8 )—R 9 —;

R 7 , R 8 and R 9 are independently selected from the group consisting of C 1-20 alkyl, C 2-22 alkenyl, C 6-40 cycloalkyl, C 7-40 cycloalkylene and H;

m is an integral value ranging from 1 to 100 inclusive;

x is an integral value ranging from 2 to 1,000 with the proviso that when —O—Y is a C 3-20 alkyl glycol ether, x is an integral value no less than 7; and

no more than two of R 1 , R 2 , R 3 and R 4 are terminated with an hydroxyl group;

wherein:

each R 1 , R 2 , R 3 , R 4 and R 5 can be the same or different and independently selected from the group consisting of C 12-20 alkyl, C 12-22 alkenyl, C 12-40 cycloalkyl, C 12-40 cycloalkenyl, C 12-20 alkyl glycol ethers and A-OH and B—OH as an end-capping groups;

each A and B are different and independently selected from the group consisting of C 2-40 alkylene, C 7-40 cycloalkylene, C 3-20 alkyl glycol ethers, C 3-40 alkyl lactone, and —R 7 —N(R 8 )—R 9 — wherein R 7 , R 8 and R 9 are independently selected from the group C 1-20 alkyl, C 2-22 alkenyl, C 6-40 cycloalkyl, C 7-40 cycloalkylene and H;

m and n are integral values ranging from 1 to 100 inclusive;

x and y are integral values ranging from 1 to 1,000 wherein x+y sum to at least 3, with the proviso that when —O-A or —O—B are C 3-20 alkyl glycol ethers, at least one of x or y is an integral value no less than 7; and

no more than two of R 1 , R 2 , R 3 , R 4 and R 5 are terminated with a hydroxyl group;

wherein:

each R 1 , R 2 , R 5 and R 6 can be the same or different and independently selected from the group consisting of C 1-20 alkyl, C 2-22 alkenyl, C 6-40 cycloalkyl, C 7-40 cycloalkylene, C 3-20 methoxy alkyl glycol ethers, C 3-20 alkyl glycol ethers or Y—OH (serving as an end capping moiety) for R 1 , R 2 , R 5 and R 6 ;

Y is selected from the group consisting of C 2-40 alkylene, C 2-40 alkyl lactone, and C 2-40 cycloalkyl and further comprises C 2-20 alkyl glycol ethers when Y is in the polyphosphite backbone; and

x is an integral value ranging from 8 to 1,000; and

wherein:

where each R 1 , R 2 , R 3 , R 4 , R 5 and R 6 can be the same or different and independently selected from the group consisting of C 1-20 alkyl, C 2-22 alkenyl, C 6-40 cycloalkyl, C 7-40 cycloalkylene, C 3-20 methoxy alkyl glycol ethers, C 3-20 alkyl glycol ethers or Y—OH (serving as an end capping moiety) for R 1 , R 2 , R 3 , R 4 , R 5 and R 6 ;

Y is selected from the group consisting of C 2-40 alkylene, C 2-40 alkyl lactone, and C 2-40 cycloalkyl and further comprises C 2-20 alkyl glycol ethers when Y is in the polyphosphite backbone (e.g., ethylene, propylene, caprylactone, polyalkylene glycol);

x is an integral value ranging from 8 to 1,000;

z is an integral value ranging from 0 to 1,000 with the proviso that when z is 8 or greater, then x is an integral value ranging from 1 to 1,000;

m is an integral value ranging from 1 to 20; and

w is an integral value ranging from 1 to 1,000.

10 . The polymer composition of claim 1 , wherein the one or more polyamides is PA-12.

11 . The polymer composition of claim 1 , wherein each of the one or more polyphosphites has:

a number average molecular number (M n ) in the range of from 500 to 5,000 g/mol;

a weight average molecular weight (M w ) in the range of from 1,000 to 10,000 g/mol; or

a combination thereof.

12 . The polymer composition of claim 1 , wherein:

the polymer composition comprises an ethylene copolymer comprising units derived from ethylene and units derived from one or more C 3 to C 20 α-olefins; and

the ethylene copolymer has density within the range from 0.905 to 0.945 g/cm 3 and melt index (ASTM D1238 at 190° C., 2.16 kg loading) within the range from 0.1 to 5.0 g/10 min.

13 . The polymer composition of claim 12 , wherein the ethylene copolymer is metallocene-catalyzed linear low density polyethylene (mLLDPE), comprising units derived from ethylene and units derived from 1-butene, 1-hexene, or 1-octene.

14 . The polymer composition of claim 1 , wherein the polymer composition has been formed by a process comprising melt-blending the mixture of one or more polyamides and one or more polyphosphites and the homopolymer or copolymer so as to obtain the polymer composition having homogenously distributed mixture among the homopolymer or copolymer.

15 . The polymer composition of claim 1 , wherein at least a portion of the polymer processing aid is provided to the polymer composition in the form of a masterbatch comprising the polymer processing aid in a carrier resin.

16 . A blown film made from the polymer composition of claim 1 , wherein the film, when compared to a benchmark film, has:

i. a 1% secant modulus (MD) within ±15% of the value (psi) of the benchmark film;

ii. a dart drop within ±15% of the value (g) of the benchmark film;

iii. an Elmendorf tear (MD) within ±20% of the value (g/mil) benchmark film;

iv. a MD gloss 45° within ±15 GU of the value (in GU) of the benchmark film, and/or MD gloss 45° greater than or equal to 40 GU;

v. a total haze within ±15% haze of the value (in % haze) of the benchmark film, and/or total haze less than or equal to 20%; or

vi. a combination thereof;

wherein the benchmark film is made using a fluoropolymer-based polymer processing aid instead of the polymer processing aid comprising the mixture of one or more polyamides and one or more polyphosphites but is otherwise identical to the film.

Continuity (2)
Provisional Application 63712136 · Oct 25, 2024
Related Publication 20260117053A1 · Apr 30, 2026
References Cited (129)
US 3222314A · Wolinski · 1965 [cited by applicant]
US 4013622A · DeJuneas et al. · 1977 [cited by applicant]
US 4327009A · Allen et al. · 1982 [cited by applicant]
US 4415691A · Allen et al. · 1983 [cited by applicant]
US 4540538A · Corwin et al. · 1985 [cited by applicant]
US 4855360A · Duchesne et al. · 1989 [cited by applicant]
US 5015693A · Duchesne et al. · 1991 [cited by applicant]
US 5550193A · Chiu et al. · 1996 [cited by applicant]
US 6124428A · Schmieg et al. · 2000 [cited by applicant]
US 6294604B1 · Focquet et al. · 2001 [cited by applicant]
US 7041742B2 · Panek et al. · 2006 [cited by applicant]
US 7442742B1 · Smink et al. · 2008 [cited by applicant]
US 7528185B2 · Lee · 2009 [cited by applicant]
US 8178479B2 · Cernohous · 2012 [cited by applicant]
US 8388868B2 · Easter · 2013 [cited by applicant]
US 8455580B2 · Sengupta et al. · 2013 [cited by applicant]
US 8552136B2 · Papp et al. · 2013 [cited by applicant]
US 8563637B2 · Jakupca · 2013 [cited by examiner]
US 8728370B2 · Vogt et al. · 2014 [cited by applicant]
US 9115274B2 · Bates · 2015 [cited by applicant]
US 9187629B2 · Adamczyk et al. · 2015 [cited by applicant]
US 9630349B2 · Chatterjee et al. · 2017 [cited by applicant]
US 9896575B2 · Duchesne et al. · 2018 [cited by applicant]
US 9920285B2 · Wakita · 2018 [cited by applicant]
US 10030108B1 · Lau et al. · 2018 [cited by applicant]
US 10242769B2 · Kohri et al. · 2019 [cited by applicant]
US 10358506B2 · Ding et al. · 2019 [cited by applicant]
US 10544293B2 · Kohri et al. · 2020 [cited by applicant]
US 10982079B2 · Claude et al. · 2021 [cited by applicant]
US 11472928B2 · Jakupca et al. · 2022 [cited by applicant]
US 11643534B2 · Ruocco et al. · 2023 [cited by applicant]
US 11746219B2 · Canright et al. · 2023 [cited by applicant]
US 12018142B2 · Leaf et al. · 2024 [cited by applicant]
US 20030040695A1 · Zhao et al. · 2003 [cited by applicant]
US 20040024138A1 · Allermann · 2004 [cited by applicant]
US 20050070644A1 · Tikuisis et al. · 2005 [cited by applicant]
US 20060217490A1 · Lee et al. · 2006 [cited by applicant]
US 20070087118A1 · Tang et al. · 2007 [cited by applicant]
US 20080132654A1 · Ho et al. · 2008 [cited by applicant]
US 20080318065A1 · Sherman et al. · 2008 [cited by applicant]
US 20090043012A1 · Easter · 2009 [cited by applicant]
US 20100216923A1 · Stevenson et al. · 2010 [cited by applicant]
US 20120059102A1 · Cernohous et al. · 2012 [cited by applicant]
US 20130068498A1 · Adamczyk et al. · 2013 [cited by applicant]
US 20130244522A1 · Knack · 2013 [cited by applicant]
US 20140182882A1 · Adamczyk et al. · 2014 [cited by applicant]
US 20140242314A1 · Inn et al. · 2014 [cited by applicant]
US 20150175785A1 · Lavallee et al. · 2015 [cited by applicant]
US 20150315401A1 · Lee · 2015 [cited by applicant]
US 20160145427A1 · Eng et al. · 2016 [cited by applicant]
US 20160229994A1 · Claude et al. · 2016 [cited by applicant]
US 20170342245A1 · Lavallee et al. · 2017 [cited by applicant]
US 20200308379A1 · Rousseaux et al. · 2020 [cited by applicant]
US 20200325314A1 · Bergqvist et al. · 2020 [cited by applicant]
US 20220112363A1 · Hamad et al. · 2022 [cited by applicant]
US 20230036922A1 · Leaf et al. · 2023 [cited by applicant]
US 20230202089A1 · Wasylenko et al. · 2023 [cited by applicant]
US 20230265269A1 · Saba et al. · 2023 [cited by applicant]
US 20230399426A1 · Li et al. · 2023 [cited by applicant]
US 20240140012A1 · Taylor et al. · 2024 [cited by applicant]
US 20240218129A1 · Taylor · 2024 [cited by examiner]
US 20240392121A1 · Van Hoyweghen et al. · 2024 [cited by applicant]
US 20250034376A1 · Longanecker et al. · 2025 [cited by applicant]
CA 641321A · 1962 [cited by applicant]
CA 2264463A1 · 2000 [cited by applicant]
CA 3176575A1 · 2021 [cited by applicant]
CN 103819782A · 2014 [cited by applicant]
CN 102746563B · 2014 [cited by applicant]
CN 104277300A · 2015 [cited by applicant]
CN 104403170A · 2015 [cited by applicant]
CN 103772789B · 2016 [cited by applicant]
CN 105542303A · 2016 [cited by applicant]
CN 104558751B · 2017 [cited by applicant]
CN 107312231A · 2017 [cited by applicant]
CN 107540920A · 2018 [cited by applicant]
CN 107955244A · 2018 [cited by applicant]
CN 109535541A · 2019 [cited by applicant]
CN 110317383A · 2019 [cited by applicant]
CN 107540920B · 2019 [cited by applicant]
CN 108481855B · 2020 [cited by applicant]
CN 112029173A · 2020 [cited by applicant]
CN 108503937B · 2021 [cited by applicant]
CN 110105627B · 2021 [cited by applicant]
CN 111849050B · 2022 [cited by applicant]
CN 112029173B · 2023 [cited by applicant]
CN 118019789A · 2024 [cited by applicant]
CN 118019793A · 2024 [cited by applicant]
CN 118019795A · 2024 [cited by applicant]
CN 118019797A · 2024 [cited by applicant]
EP 0217585A2 · 1987 [cited by applicant]
EP 0308090A2 · 1989 [cited by applicant]
EP 0524404A1 · 1993 [cited by applicant]
EP 1160278A1 · 2001 [cited by applicant]
EP 0859025B1 · 2003 [cited by applicant]
EP 1839851A2 · 2007 [cited by applicant]
EP 2473265A1 · 2012 [cited by applicant]
EP 3234004B1 · 2020 [cited by applicant]
EP 3908627A1 · 2021 [cited by applicant]
EP 4408920A2 · 2024 [cited by applicant]
EP 4408921A1 · 2024 [cited by applicant]
EP 4408924A1 · 2024 [cited by applicant]
JP 2011032399A · 2011 [cited by applicant]
JP 2012009754A · 2012 [cited by applicant]
JP 5525932B2 · 2014 [cited by applicant]
KR 1020200053903A · 2020 [cited by applicant]
KR 102167728B1 · 2020 [cited by applicant]
WO 1998010928A1 · 1998 [cited by applicant]
WO 2005054315A1 · 2005 [cited by applicant]
WO 2011028206A1 · 2011 [cited by applicant]
WO 2012123357A1 · 2012 [cited by applicant]
WO 2013023247A1 · 2013 [cited by applicant]
WO 2017077455A2 · 2017 [cited by applicant]
WO 2020100001A1 · 2020 [cited by applicant]
WO 2020146351A1 · 2020 [cited by applicant]
WO 2021220134A1 · 2021 [cited by applicant]
WO 2022076296A1 · 2022 [cited by applicant]
WO 2022079601A1 · 2022 [cited by applicant]
WO 2022120321A1 · 2022 [cited by applicant]
WO 2023285888A1 · 2023 [cited by applicant]
WO 2023056213A1 · 2023 [cited by applicant]
WO 2023056250A1 · 2023 [cited by applicant]
WO 2023149984A1 · 2023 [cited by applicant]
WO 2023149985A1 · 2023 [cited by applicant]
WO 2023154744A1 · 2023 [cited by applicant]
WO WO2025068546 · 2025 [cited by applicant]
Akers, M. J. et al., (2002) “Formulation Development of Protein Dosage Forms”, Development and Manufacture of Protein Pharmaceuticals, pp. 47-75. [cited by applicant]
Schiweck, H. et al., (Jan. 15, 2012) “Sugar Alcohols”, Ullman's Encyclopedia of Industrial Chemistry, pp. 1-37. [cited by applicant]
Benson, F.R. in M. Schick (ed.): Nonionic Surfactants, Marcel Dekker, New York 1967, p. 247. [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2025/043476 dated Dec. 2, 2025. PDF file. 11 pages. [cited by applicant]